DNTH
#1276
Dianthus Therapeutics, Inc. - Common Stock
101.2 8 USD
+0.03%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+2.68%
Changement Mensuel
+22.75%
Evolution sur 6 mois
+128.52%
Changement Annuel
+428.33%
Clôture Précédente
98.6 4
Open
101.3 6
Low
101.2 8
High
101.3 6
Volume
172
Financials
- Market Capitalization 5.54 B
- Employee 92
- Founded 2019
- CEO N/A
- Website www.dianthustx.com
- Headquarter Delaware, United States
- FIGI BBG00FB2NPZ0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-19.84
ratio cours/chiffre d'affaires
547.28
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1221 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 300.97 USD | -2.68% | -6.50% | +17.98% | +60.84% | 6.03 B USD | ||
| 1250 |  BLTE Belite Bio Inc - American Depositary Shares | 146.68 USD | -0.24% | -5.67% | +1.17% | +132.42% | 5.77 B USD | ||
| 1286 |  CELC Celcuity Inc. - Common Stock | 111.05 USD | +6.99% | -2.59% | +25.42% | +700.65% | 5.42 B USD | ||
| 1299 |  TVTX Travere Therapeutics, Inc. - Common Stock | 57.06 USD | +1.37% | -0.77% | +5.90% | +98.33% | 5.31 B USD |